Сравнительная оценка методов визуализации в ранней диагностики рака молочной железы

Kinne D.W., Petrek J.A., Osborne M.P. et al. Breast carcinoma in situ // Arch. Surg. -1989. -V.124. -P.33-40.

Koli K.M., Arteaga C.L. Transforming growth factor-beta and breast cancer. In: Bowcock A, ed. Breast cancer: molecular genetics, pathogenesis, and therapeutics. -Totowa, NJ: Humana Press, 1999. -P.95-101.

Lagios M., Richards V., Rose M., Yee E. Segmental mastectomy without radiotherapy: short-term follow-up // Cancer. -1983. -P.52. -P.2173-2180.

Lagios M.D. Microinvasion in ductal carcinoma in situ. -In: Silverstein M.J. et al. Carcinoma in situ of the breast. -Baltimore: Williams & Wilkins, 1997. -P.241-248.

Lazovich D., Solomon C.C., Thomas D.B. et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage breast cancer // Cancer. -1999. -V.86. -P.628-634.

Liberman L., Cohen M.A., Dershaw D.D. et al. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy // AJR Am. J. Roentgenol. -1995. -V.164. -P.1111-1117.

Liberman L., La Trenta L.R., Dershaw D.D. et al. Impact of core biopsy on the surgical management of impalpable breast cancer // AJR Am. J. Roentgenol. -1997. -V.168. -P.495-501.

Lim M., Nixon A., Gelman R. et al. A prospective study of conservative surgery alone without radiotherapy in selected patients with stage I breast cancer // Breast Cancer Res. Treat. -1999. -V.57. -P.34-39. (abst).

Lindley C., Vasa S., Sawyer W., Winer E. Quality of life and preferences for treatment following systemic adjuvant therapy for early stage breast cancer // J. Clin. Oncol. -1998. -V.16. -P.1380-1390.

Martinez-Lacaci I., Bianco C., DeSantis M., Salomon D.S. Epidermal growth factor-related peptides and their cognate receptors in breast cancer. -In: Bowcock A. et al. Breast cancer: molecular genetics, pathogenesis, and therapeutics. -Totowa, N.J.: Humana Press, 1999. -P.31-37.

McCormick B., Rosen P.P., Kinne D. et al. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. -1991. -V.21. -P.289-293.

Melbye M., Wohlfahrt J., Olsen J. Induced abortion and the risk of breast cancer // N. Engl. J. Med. -1997. -V.336. -P.81-86.

Meyer J., Eberlein T., Stomper P. et al. Biopsy of occult breast lesions // JAMA. -1990. -V.263. -P.2341-2348.

Montgomery A., Greening W., Levene A. Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy // J. R. Soc. Med. -1978. -V.71. -P.339-344.

Morrow M., Schmidt R., Hassett C. Patient selection for breast conservation therapy with magnification mammography // Surgery. -1995. -V.118. -P.621-627.

Morrow M., Venta L., Stinson T. et al. Is core biopsy the diagnostic procedure of choice for all mammographic abnormalities? // Proc. Am. Soc. Clin. Oncol. -1999. -V.18. -P.79a-85a.

Morrow M., Winchester D.P., Chmiel J.S. et al. Factors responsible for the under-utilization of breast-conserving therapy // Proc. Am. Soc. Clin. Oncol. -1998. -V.17. -P.98a-104. (abst).

Morrow M. When can stereotactic core biopsy replace excisional biopsy? A clinical perspective // Breast Cancer Res. Treat. -1995. -V.36. -P.1-12.

Pandya S., Mackarem G., Lee A.K.C. et al. Ductal carcinoma in situ: the impact of screening on clinical presentation and pathologic features // Breast J. -1998. -№4. -P.146-150.

Park C.C., Mitsumori M., Nixon A. et al. Outcome at 8 years after breast conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence // J. Clin. Oncol. -2000. -V.18. -№ 8. -P.1668-1676.

Phillips K.A., Glendon G., Knight J. Putting the risk of breast cancer in perspective // N. Engl. J. Med. -1999. -V.340. -P.141-148.

Ried T., Just K.E., Holtgreve-Grez H. et al. Comparative genomic hybridization of formalin fixed, paraffin embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas // Cancer Res. -1995. -V.55. -P.5415-5419.

Rosfjord E.C., Dickson R.B. Growth factors, apoptosis, and survival of mammary epithelial cells // J. Mammary Gland. Biol. Neoplasia. -1999. -№4. -P.229-235.

Rosner B., Colditz G., Willett W. Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study // Am. J. Epidemiol. -1994. -V.139. -P.819-825.

Rudas M., Neumayer R., Gnant M.F. et al. p53 protein expression, cell proliferation, and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast // Eur. J. Cancer. -1997. -V.33. -P.39-45.

Salmon R., Ansquer Y., Asselain B. et al. Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause // Oncol. Rep. -1999. -№6. -P.699-705.

Silver S.A., Tavassoli F.A. Mammary ductal carcinoma in situ with microinvasion // Cancer. -1998. -V.82. -P.2382-2387.

Silverstein M.J., Lagios M.D., Craig P.H. et al. A prognostic index for ductal carcinoma in situ of the breast // Cancer. -1996. -V.77. -P.2267-2273.

Silverstein M.J., Poller D.N., Waisman J.R. et al. Prognostic classification of breast ductal carcinoma in situ // Lancet. -1995. -V.345. -P.1154-1162.

Silverstein M.J. Van Nuys experience by treatment. -In: Silverstein M.J. et al. Ductal carcinoma in situ of the breast. -Baltimore: Williams & Wilkins, 1997. -P.443-449.

Smith I.E., Gregory K. The sequencing of systemic and local therapies in primary breast cancer // Semin. Breast Dis. -1999. -№2. -P.110.

Solin L.J., McCormick B., Recht A. et al. Mammographically detected clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast-conserving surgery and definitive breast irradiation // Cancer J. Sci. Am. -1996. -№2. -P.158-165.

Solin L.J., Kurtz J., Fourquet A. et al. Fifteen year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast // J. Clin. Oncol. -1996. -V.14. -P.754-761.

The Consensus Conference Committee. Consensus conference of the classification of ductal carcinoma in situ // Cancer. -1997. -V.80. -P.1798-1805.

Thompson W., Bowen J., Dorman B. et al. Mammographic localization and biopsy of nonpalpable breast lesions: a 5-year study // Arch. Surg. -1991. -V.126. -P.730-737.

Tinnemans J., Wobbes T., Holland R. et al. Mammographic and histopathologic correlation of nonpalpable lesions of the breast and the reliability of frozen section diagnosis // Surg. Gynecol. Obstet. -1987. -V.165. -P.523-528.

van Tienhoven G., Voogd A.C., Peterse J.L. et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM) // Eur. J. Cancer. -1999. -V.35. -P.32-37.

Van Zee K., Liberman L., Samli B. et al. Long-term follow up of women with ductal carcinoma in situ treated with breast-conserving surgery // Cancer. -1999. -V.86. -P.1757-1763.

Vetto J., Jun S.Y., Padduch D. et al. Stages at presentation, prognostic factors, and outcome of breast cancer in males // Am. J. Surg. -1999. -V.177. -P.379-384.

Vos C.B., Cleton-Jansen A.M., Berx G. et al. E-cadherin inactivation in lobular carcinoma in situ of the breast; an early event in tumorigenesis // Br. J. Cancer. -1997. -V.76. -P.1131-1138.

Wolff A.C., Davidson N.E. Primary systemic therapy in operable breast cancer // J. Clin. Oncol. -2000. -V.18. -P.1558-1565.

Размещено на Allbest.ru